Premium
TRANSCRIPTIONAL AND GENOMIC INTRA‐TUMOR HETEROGENEITY DRIVES SUBCLONE SPECIFIC DRUG RESPONSES IN DIFFUSE LARGE B CELL LYMPHOMA
Author(s) -
Roider T.,
Frauhammer F.,
Seufert J.,
Bordas M.,
Stolarczyk M.,
Rabe S.,
Malm J.,
Bruch P.,
Hundemer M.,
Rippe K.,
Goeppert B.,
Seiffert M.,
Brors B.,
Mechtersheimer G.,
MüllerTidow C.,
Fröhling S.,
Schlesner M.,
Huber W.,
Anders S.,
Dietrich S.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.45_2629
Subject(s) - biology , diffuse large b cell lymphoma , lymphoma , population , lymph node , tumor microenvironment , immunophenotyping , cell sorting , lineage markers , cancer research , gene , pathology , flow cytometry , microbiology and biotechnology , phenotype , immunology , genetics , medicine , tumor cells , environmental health